Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Health
Storm Newton

Weight loss drugs could slash hospital risk for heart failure patients

The price of the drug will drop (Alamy/PA) -

The weight loss and type 2 diabetes drugs semaglutide and tirzepatide – sold under the brand names Ozempic, Wegovy and Mounjaro – could slash the risk of patients with a type of heart failure ending up in hospital, a study has found.

Experts compared the drugs to sitagliptin, a medication used to manage blood sugar in people with type 2 diabetes, for patients with heart failure with preserved ejection fraction (HFpEF).

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.